Skip to main content
. 2022 Sep 30;13:973655. doi: 10.3389/fendo.2022.973655
BCF NGT (n=276) IGR (n=323) DM (n=315)
TyG r P r P r P
Late-phase BCF indices
I120/I0ratio DI -0.180a 0.023 -0.256e <0.001 -0.283k <0.001
CP120/CP0ratio DI -0.233b 0.003 -0.369f <0.001 -0.325k <0.001
△I120/△G120 ratio DI 0.012c 0.878 0.012g; 0.866 -0.192l 0.005
△CP120/△G120ratio DI 0.027c 0.737 -0.032h 0.4658 -0.181m 0.009
CIR120x10-2 DI -0.045d 0.577 -0.216i 0.002 -0.374n <0.001
Stumvoll second phase x10-2 DI -0.166d 0.037 -0.254J <0.001 -0.253o <0.001

A, DBP ajusted; b, SBP, DBP, HbA1C ajusted; c, HDL ajusted; d, Gender, SBP, DBP, TC, HbA1C ajusted; e, Age ajusted; f, Age, HbA1C ajusted; g, TC ajusted; h, HbA1c ajusted; i, Age, HbA1C, HDL, FCP, FINS ajusted; j, i+TC ajusted; k, Gender,Age, DBP, HbA1C, HDL FCP, FINS ajusted; l, Gender, DBP, HbA1C, HDL ajusted; m, Age,. SBP, DBP, HbA1C, HDL, FCP, FINS ajusted; n, Gender, HbA1C, HDL ajusted; o, Age, Gender, TC, HbA1C, FCP, FINS ajusted.